MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Acute bronchitis due to respiratory syncytial virus (J20.5)

HealthDay 10 July at 10.23 PM

Nirsevimab Effective Against RSV-Linked Bronchiolitis Hospitalization

Nirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants, according to a study published in the July 11 issue of the New England Journal of Medicine.Zein Assad, M.D., from the Robert Debré University Hospital in Paris, and colleagues conduct

HealthDay 27 June at 11.32 AM

CDC Strengthens RSV Vaccine Advice for Those Over 75

In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall arrives.However, those a bit younger -- ages 60 to 74 -- should only seek the shot if they are vulnerable to severe RSV because of chronic medical conditions such as lung or heart disease, or if

HealthDay 16 January at 11.49 PM

CDC: Although Season Not Over, Flu Activity Is Slowing Down

For the first time in months, there has been "a single-week decrease" in flu activity, according to data released by the U.S. Centers for Disease Control and Prevention.But health officials warn that the flu season is far from over, with a surge expected shortly. "Folks try not to seek care

HealthDay 28 December at 11.36 PM

Nearly Half of U.S. COVID-19 Cases Now Caused by JN.1 Variant

The JN.1 variant, a descendant of the variant BA.2.86, now accounts for 44 percent of COVID-19 cases, up from roughly 7 percent in late November, the latest data from the U.S. Centers for Disease Control and Prevention show.The speed at which the JN.1 variant has sprea

HealthDay 28 December at 04.55 PM

Nirsevimab Protects Infants Against RSV-Linked Hospitalization

Nirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study published in the Dec. 28 issue of the New England Journal of Medicine.Simon B. Drysdale, Ph.D., from the Centre for Neonatal and Paediatric Infections at the Un

HealthDay 21 December at 11.21 PM

Many U.S. Nursing Home Residents Have Not Been Vaccinated for Flu, COVID-19, or RSV for 2023-24

Many nursing home residents and adults have not been vaccinated for influenza, COVID-19, or respiratory syncytial virus (RSV) for the 2023 to 2024 season, according to research published in the Dec. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Hannah E. Reses, M.P.H., from the C

HealthDay 14 December at 05.00 PM

Single Dose of mRNA-1345 Vaccine Safe, Effective Against RSV in Seniors

A single dose of mRNA-1345 vaccine is safe and results in lower incidence of respiratory syncytial virus (RSV)-associated disease in older patients, according to a study published in the Dec. 14 issue of the New England Journal of Medicine.Eleanor Wilson, M.D., from Moderna in Cambridge, Massachusetts, and colleagues conducted a rando